搜索
Cytokinetics Inc
CYTK添加自选
87.260USD
+5.070+6.17%
收盘 06/29, 16:00（美东）报价延迟15分钟
11.83B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月11日 周一
更新时间: 5月11日 周一
持股股东
股东类型
持股股东
持股股东
占比
T. Rowe Price Investment Management, Inc.
13.07%
BlackRock Institutional Trust Company, N.A.
10.32%
Fidelity Management & Research Company LLC
6.98%
Wellington Management Company, LLP
5.85%
Vanguard Portfolio Management, LLC
4.31%
其他
59.46%
持股股东
持股股东
占比
T. Rowe Price Investment Management, Inc.
13.07%
BlackRock Institutional Trust Company, N.A.
10.32%
Fidelity Management & Research Company LLC
6.98%
Wellington Management Company, LLP
5.85%
Vanguard Portfolio Management, LLC
4.31%
其他
59.46%
股东类型
持股股东
占比
Investment Advisor
58.20%
Investment Advisor/Hedge Fund
27.14%
Hedge Fund
11.62%
Research Firm
5.15%
Private Equity
1.75%
Pension Fund
1.36%
Sovereign Wealth Fund
0.60%
Bank and Trust
0.56%
Venture Capital
0.48%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
854
147.01M
109.63%
-14.94M
2025Q4
793
145.87M
132.55%
+143.08K
2025Q3
805
145.72M
135.77%
+5.80M
2025Q2
770
139.91M
134.15%
-2.00M
2025Q1
775
138.52M
127.32%
-13.28M
2024Q4
762
134.92M
129.12%
-4.79M
2024Q3
753
139.74M
126.19%
+1.20M
2024Q2
746
139.12M
110.33%
+17.80M
2024Q1
717
121.51M
118.33%
-2.47M
2023Q4
646
117.46M
121.21%
+4.93M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
T. Rowe Price Investment Management, Inc.
17.72M
14.38%
-1.36M
-7.15%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
13.99M
11.36%
+381.19K
+2.80%
Dec 31, 2025
Fidelity Management & Research Company LLC
9.47M
7.69%
+39.59K
+0.42%
Dec 31, 2025
Wellington Management Company, LLP
7.94M
6.44%
+528.50K
+7.13%
Dec 31, 2025
State Street Investment Management (US)
5.83M
4.73%
+207.96K
+3.70%
Dec 31, 2025
Deep Track Capital LP
3.34M
2.71%
-963.00K
-22.40%
Dec 31, 2025
Geode Capital Management, L.L.C.
3.06M
2.48%
+15.81K
+0.52%
Dec 31, 2025
BofA Global Research (US)
2.88M
2.33%
-133.05K
-4.42%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ALPS Medical Breakthroughs ETF
3.11%
Tema Heart & Health ETF
2.03%
State Street SPDR S&P Biotech ETF
1.58%
T Rowe Price Capital Appreciation Equity ETF
1.38%
Virtus LifeSci Biotech Clinical Trials ETF
1.3%
ProShares Ultra Nasdaq Biotechnology
0.99%
Direxion Daily S&P Biotech Bull 3X Shares
0.97%
First Trust Mid Cap Growth AlphaDEX Fund
0.76%
Invesco Nasdaq Biotechnology ETF
0.74%
iShares Biotechnology ETF
0.66%
查看更多
ALPS Medical Breakthroughs ETF
占比3.11%
Tema Heart & Health ETF
占比2.03%
State Street SPDR S&P Biotech ETF
占比1.58%
T Rowe Price Capital Appreciation Equity ETF
占比1.38%
Virtus LifeSci Biotech Clinical Trials ETF
占比1.3%
ProShares Ultra Nasdaq Biotechnology
占比0.99%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.97%
First Trust Mid Cap Growth AlphaDEX Fund
占比0.76%
Invesco Nasdaq Biotechnology ETF
占比0.74%
iShares Biotechnology ETF
占比0.66%
